We are live on
!
Find out more
WC
Woodstock Corp Portfolio holdings
AUM
$1.2B
1-Year Est. Return
26.37%
This Fund
S&P 500
This Quarter
Est. Return
-0.44%
1 Year Est. Return
+26.37%
3 Year Est. Return
+96.13%
5 Year Est. Return
+140.78%
10 Year Est. Return
+511.51%
AUM
$531M
AUM Growth
-$8.26M
(-1.5%)
Cap. Flow
-$3.33M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
23%
Holding
170
New
2
Increased
45
Reduced
60
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWN
Southwestern Energy Company
SWN
|
+$1.47M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$846K |
| 3 |
United Natural Foods
UNFI
|
+$832K |
| 4 |
SWI
SOLARWINDS INC COM STK (DE)
SWI
|
+$463K |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$454K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Karyopharm Therapeutics
KPTI
|
+$1.19M |
| 2 |
ExxonMobil
XOM
|
+$585K |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$500K |
| 4 |
Procter & Gamble
PG
|
+$494K |
| 5 |
CDK
CDK Global, Inc.
CDK
|
+$466K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.94% |
| 2 | Technology | 13.75% |
| 3 | Industrials | 12.06% |
| 4 | Consumer Staples | 10.11% |
| 5 | Energy | 8.69% |
Similar funds
SGDR
VC
FCCPG
HCM
MB
LWIC
AIM
CA
Woodstock Corp's Q2 2015 Portfolio in Review
As of Q2 2015, Woodstock Corp held 170 positions worth $531M, down 1.5% from $539M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Woodstock Corp's Q2 2015 filing shows 2 new, 45 increased, 60 reduced and 7 closed positions. Its largest new stake was Neurocrine Biosciences: 19,955 shares worth $953K. The largest sale was Karyopharm Therapeutics, an estimated $1.19M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.
- Woodstock Corp's largest Q2 2015 buy was Neurocrine Biosciences: 19,955 shares worth $953K.
- Woodstock Corp added most to Southwestern Energy Company in Q2 2015, an estimated $1.47M increase.
- Woodstock Corp's biggest Q2 2015 reduction was ExxonMobil, cutting an estimated $585K.
- Woodstock Corp fully exited Karyopharm Therapeutics in Q2 2015, selling an estimated $1.19M.
- Woodstock Corp's ten largest holdings make up 23% of its $531M portfolio in Q2 2015.
- Woodstock Corp opened 2 new positions and closed 7 in Q2 2015.
- Woodstock Corp's portfolio value fell 1.5% quarter-over-quarter to $531M.
Based on Woodstock Corp's 13F filing for Q2 2015, filed 7 Jul 2015.